Mursaleen L - Search Results

1

Co-Administration of Iron and a Bioavailable Curcumin Supplement Increases Serum BDNF Levels in Healthy Adults.

Tiekou Lorinczova H, Fitzsimons O, Mursaleen L, Renshaw D, Begum G, Zariwala MG. Tiekou Lorinczova H, et al. Among authors: mursaleen l. Antioxidants (Basel). 2020 Jul 22;9(8):645. doi: 10.3390/antiox9080645. Antioxidants (Basel). 2020. PMID: 32707771 Free PMC article.

2

Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity.

Mursaleen L, Somavarapu S, Zariwala MG. Mursaleen L, et al. J Parkinsons Dis. 2020;10(1):99-111. doi: 10.3233/JPD-191754. J Parkinsons Dis. 2020. PMID: 31868679

3

N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson's Disease.

Mursaleen L, Noble B, Chan SHY, Somavarapu S, Zariwala MG. Mursaleen L, et al. Antioxidants (Basel). 2020 Jul 9;9(7):600. doi: 10.3390/antiox9070600. Antioxidants (Basel). 2020. PMID: 32660079 Free PMC article.

4

Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson's Related Oxidative Stress in an In Vitro hCMEC/D3-SH-SY5Y Co-Culture System.

Mursaleen L, Noble B, Somavarapu S, Zariwala MG. Mursaleen L, et al. Antioxidants (Basel). 2021 May 31;10(6):887. doi: 10.3390/antiox10060887. Antioxidants (Basel). 2021. PMID: 34073115 Free PMC article.

5

Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson's Disease.

Mursaleen L, Chan SHY, Noble B, Somavarapu S, Zariwala MG. Mursaleen L, et al. Antioxidants (Basel). 2023 Jan 5;12(1):130. doi: 10.3390/antiox12010130. Antioxidants (Basel). 2023. PMID: 36670992 Free PMC article.

6

Challenges of Improving Patient-Centred Care in Parkinson's Disease.

Mathur S, Mursaleen L, Stamford J, DeWitte S, Robledo I, Isaacs T. Mathur S, et al. Among authors: mursaleen l. J Parkinsons Dis. 2017;7(1):163-174. doi: 10.3233/JPD-160922. J Parkinsons Dis. 2017. PMID: 27858720

7

Attitudes Towards Data Collection, Ownership and Sharing Among Patients with Parkinson's Disease.

Mursaleen LR, Stamford JA, Jones DA, Windle R, Isaacs T. Mursaleen LR, et al. J Parkinsons Dis. 2017;7(3):523-531. doi: 10.3233/JPD-161045. J Parkinsons Dis. 2017. PMID: 28671139

8

GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.

Barker RA, Björklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells AP, Fiandaca MS, Stoessl AJ, Eidelberg D, Federoff H, Voutilainen MH, Dexter DT, Eberling J, Brundin P, Isaacs L, Mursaleen L, Bresolin E, Carroll C, Coles A, Fiske B, Matthews H, Lungu C, Wyse RK, Stott S, Lang AE. Barker RA, et al. Among authors: mursaleen l. J Parkinsons Dis. 2020;10(3):875-891. doi: 10.3233/JPD-202004. J Parkinsons Dis. 2020. PMID: 32508331 Free PMC article. Review.

9

Waiting for PARIS-A Biological Target in Search of a Drug.

Wyse RK, Stott SRW, Mursaleen L, Matthews H, Dawson VL, Dawson TM. Wyse RK, et al. Among authors: mursaleen l. J Parkinsons Dis. 2022;12(1):95-103. doi: 10.3233/JPD-212945. J Parkinsons Dis. 2022. PMID: 34744054 Free PMC article.

10

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update.

McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, Stott SRW. McFarthing K, et al. Among authors: mursaleen l. J Parkinsons Dis. 2022;12(4):1073-1082. doi: 10.3233/JPD-229002. J Parkinsons Dis. 2022. PMID: 35527571 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page